Tech Center 3700 • Art Units: 3731 3771
This examiner grants 66% of resolved cases
Anh Tieu Dang operates within Art Unit 3731 of Tech Center 3700, where he has handled 660 resolved cases. His overall allowance rate of 65.5% serves as a primary indicator of his disposition toward applications. For practitioners, the interview lift of 35.5% is a critical figure, as it shows that verbal engagement with the examiner significantly improves the chances of reaching an allowance.
The median days to allowance for this examiner is 1220. This timeline indicates that applicants should prepare for a prosecution cycle lasting over three years. The 65.5% allowance rate, combined with the 35.5% interview lift, suggests that while the process may be lengthy, active advocacy through interviews is highly effective. In Art Unit 3731, the 1220-day median pendency is a key planning factor for those managing 660 resolved cases or similar portfolios.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19189539 | ARTICULATION MECHANISMS AND METHODS OF USE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18070531 | SURGICAL INSTRUMENT WITH SELECTOR | Non-Final OA | Cilag GmbH International |
| 16612035 | DEVICE TO FACILITATE PERFORMING DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK) | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18967745 | KNIFE FOR CANNULATED SURGERY | Final Rejection | Warsaw Orthopedic, Inc. |
| 18898967 | SURGICAL INSTRUMENTS HAVING REDUCED ADHERENCE TO VITREOUS | Final Rejection | Alcon Inc. |
| 19194479 | SLOTTED CANULLA FOR ARTHROSCOPIC SURGERY | Non-Final OA | Smith & Nephew, Inc. |
| 18888585 | SURGICAL INSTRUMENTS FOR PHACOEMULSIFICATION SURGERY | Non-Final OA | Johnson & Johnson Surgical Vision, Inc. |
| 18195405 | METHOD AND SYSTEM FOR REDUCING LIMB ISCHEMIA | Non-Final OA | ABIOMED, Inc. |
| 18385019 | DEVICE AND METHOD TO REMOVE OBSTRUCTION FROM THROAT OF A USER | Final Rejection | HCL Technologies Limited |
| 18410384 | AORTIC PUNCH | Non-Final OA | The University of Toledo |
| 18427167 | Controlled Tissue Dissection Systems and Methods | Final Rejection | BioProtect Ltd. |
| 18465258 | UNIVERSAL FACIAL REJUVENATION TREATMENT SYSTEM (U-FRTS) | Non-Final OA | Skin Aesthetics Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy